All I know is, things like Trehalose are the perfect example of a stopgap. The only reason to be taking things like this is to live in a better state long enough to get to real rejuvenation therapies. That's why I'm so annoyingly impatient in these threads. If it can't work now, or in a couple years, then it's completely pointless.
The thing about atherosclerosis is that there are now half a dozen things shown to reverse it mice, including Trehalose, Cyclodextrin, PTP1B inhibitors, NAD+ precursors.... I'm not even sure I have atherosclerosis more than an average person my age. But it is still the biggest killer so I still want to target it.
Having said all that, the best overall bet includes things that you can get your hands on and deliver right now, not in 5 years, regardless of how marginal the effect may be. I take Trehalose, I have but do not take Cyclodextrin, Magnolia for the PTP1B pathway and NMN for NAD+.
As long as they are relatively safe, which is why I skip the Cyclodextrin for now, then a bunch of smaller effects should necessarily lead to a larger effect. The only drawback is that it will be more expensive until we have more powerful and targeted therapies. I can't say any of this is helping, but no one can say for sure just yet.
It would be great to have a powerful, targeted and measurable therapy. But lets look at the rectal admin. That was, in theory, a nice solution to the delivery problem. In reality though, keeping it up day to day, not knowing if it's working, just wasn't going to fly. We need cheap and easy measurements just as much as we need delivery. Sorry for the rant guys.